We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
988

Sector Composition

Rank Sector Weight
1 Technology 6.22%
2 Financials 6.16%
3 Industrials 5.09%
4 Consumer Discretionary 4.89%
5 Healthcare 4.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TREE icon
3076
LendingTree
TREE
$458M
$2.72M ﹤0.01%
7,994
+4,763
+147% +$1.35M
WPZ
3077
DELISTED
Williams Partners L.P.
WPZ
$2.72M ﹤0.01%
70,126
-32,545
-32% -$1.22M
AXTA icon
3078
CALL
Axalta
AXTA
$7.99B
$2.71M ﹤0.01%
83,800
+45,400
+118% +$1.44M
IWC icon
3079
iShares Micro-Cap ETF
IWC
$1.52B
$2.71M ﹤0.01%
28,338
+6,192
+28% +$587K
BIG
3080
CALL
DELISTED
Big Lots, Inc.
BIG
$2.71M ﹤0.01%
48,200
+1,700
+4% +$92.2K
USD icon
3081
ProShares Ultra Semiconductors
USD
$2.96B
$2.7M ﹤0.01%
1,059,504
+22,320
+2% +$56.3K
ZBH icon
3082
CALL
Zimmer Biomet
ZBH
$19.2B
$2.7M ﹤0.01%
23,072
-6,283
-21% -$710K
SIL icon
3083
PUT
Global X Silver Miners ETF NEW
SIL
$4.79B
$2.69M ﹤0.01%
82,500
+61,200
+287% +$1.96M
VIPS icon
3084
CALL
Vipshop
VIPS
$6.81B
$2.69M ﹤0.01%
229,800
+88,200
+62% +$780K
JUNO
3085
CALL
DELISTED
Juno Therapeutics, Inc.
JUNO
$2.69M ﹤0.01%
58,900
-15,300
-21% -$763K
HRL icon
3086
PUT
Hormel Foods
HRL
$13.5B
$2.69M ﹤0.01%
73,900
-27,400
-27% -$921K
CFFN icon
3087
Capitol Federal Financial
CFFN
$1.08B
$2.68M ﹤0.01%
200,185
-119,741
-37% -$1.68M
CTXS
3088
CALL
DELISTED
Citrix Systems Inc
CTXS
$2.68M ﹤0.01%
30,500
+14,200
+87% +$1.2M
BID
3089
CALL
DELISTED
Sotheby's
BID
$2.68M ﹤0.01%
52,000
+4,400
+9% +$220K
SC
3090
CALL
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
$2.68M ﹤0.01%
144,000
-64,500
-31% -$1.08M
TRN icon
3091
PUT
Trinity Industries
TRN
$2.36B
$2.68M ﹤0.01%
99,314
+43,754
+79% +$1.09M
BKF icon
3092
iShares MSCI BIC ETF
BKF
$76.5M
$2.68M ﹤0.01%
+60,172
New +$2.66M
SO icon
3093
CALL
Southern Company
SO
$107B
$2.67M ﹤0.01%
55,600
-197,600
-78% -$10.1M
VWO icon
3094
CALL
Vanguard FTSE Emerging Markets ETF
VWO
$125B
$2.67M ﹤0.01%
58,100
-9,600
-14% -$429K
XEC
3095
PUT
DELISTED
CIMAREX ENERGY CO
XEC
$2.66M ﹤0.01%
21,800
+1,800
+9% +$210K
USCR
3096
PUT
DELISTED
U S Concrete, Inc.
USCR
$2.66M ﹤0.01%
31,800
-33,900
-52% -$2.67M
VYM icon
3097
Vanguard High Dividend Yield ETF
VYM
$84B
$2.65M ﹤0.01%
+30,986
New +$2.59M
ENS icon
3098
EnerSys
ENS
$7.34B
$2.65M ﹤0.01%
38,073
-7,969
-17% -$546K
ASML icon
3099
ASML
ASML
$708B
$2.65M ﹤0.01%
15,213
+8,885
+140% +$1.57M
IOO icon
3100
iShares Global 100 ETF
IOO
$9.42B
$2.64M ﹤0.01%
+57,074
New +$2.6M

Similar funds

Ken Griffin's Q4 2017 Portfolio in Review

As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
  • Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.